Supernus Pharmaceuticals (SUPN)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:667
% of all portfolios:0.012%
History Portfolio Manager Activity Share change % change to portfolio ▲
Q3  2024
≡ Third Avenue Management Add 0.20% 375 0.00
Q2  2024
≡ Third Avenue Management Add 18.41% 29,401 0.14
Q4  2023
≡ Third Avenue Management Add 37.04% 43,168 0.21
Q3  2023
≡ Lee Ainslie - Maverick Capital Sell 100.00% 7,409 0.00
≡ Third Avenue Management Add 73.79% 49,487 0.23
Q2  2023
≡ Lee Ainslie - Maverick Capital Reduce 11.86% 997 0.00
≡ Third Avenue Management Add 2626.10% 64,602 0.32
Q1  2023
≡ Lee Ainslie - Maverick Capital Add 9.01% 695 0.00
Q4  2022
≡ Lee Ainslie - Maverick Capital Reduce 13.22% 1,175 0.00
Q3  2022
≡ Lee Ainslie - Maverick Capital Buy 8,886 0.01
Q2  2022
≡ Third Avenue Management Buy 2,460 0.01
Q1  2022
≡ Lee Ainslie - Maverick Capital Sell 100.00% 4,000 0.00
Q4  2021
≡ Lee Ainslie - Maverick Capital Reduce 90.47% 37,962 0.00
Q3  2021
≡ Lee Ainslie - Maverick Capital Reduce 26.71% 15,289 0.00
Q2  2021
≡ Lee Ainslie - Maverick Capital Buy 57,251 0.02
Q1  2021
≡ Lee Ainslie - Maverick Capital Sell 100.00% 1,711 0.00
Q4  2020
≡ Lee Ainslie - Maverick Capital Reduce 97.41% 64,466 0.00
Q3  2020
≡ Lee Ainslie - Maverick Capital Buy 66,177 0.03

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.